Renewable hydrogen supply chains: A planning matrix and an agenda for future research

Worldwide, energy systems are experiencing a transition to more sustainable systems. According to the Hydrogen Roadmap Europe (FCH EU, 2019), hydrogen will play an important role in future energy systems due to its ability to support sustainability goals and will account for approximately 13% of the total energy mix in the coming future. Correct hydrogen supply chain (HSC) planning is therefore vital to enable a sustainable transition, in particular when hydrogen is produced by water electrolysis using electricity from renewable sources (renewable hydrogen). However, due to the operational characteristics of the renewable HSC, its planning is complicated. Renewable hydrogen supply can be diverse: Hydrogen can be produced de-centrally with renewables, such as wind and solar energy, or centrally by using electricity generated from a hydro power plant with a large volume. Similarly, demand for hydrogen can also be diverse, with many new applications, such as fuels for fuel cell electrical vehicles and electricity generation, feedstocks in industrial processes, and heating for buildings. The HSC consists of various stages (production, storage, distribution, and applications) in different forms, with strong interdependencies, which further increase HSC complexity. Finally, planning of an HSC depends on the status of hydrogen adoption and market development, and on how mature technologies are, and both factors are characterised by high uncertainties. Directly adapting the traditional approaches of supply chain (SC) planning for HSCs is insufficient. Therefore, in this study we develop a planning matrix with related planning tasks, leveraging a systematic literature review to cope with the characteristics of HSCs. We focus only on renewable hydrogen due to its relevance to the future low-carbon economy. Furthermore, we outline an agenda for future research, from the supply chain management perspective, in order to support renewable HSC development, considering the different phases of renewable HSCs adoption and market development

Bevacizumab for newly diagnosed ovarian cancers: Best candidates among high-risk disease patients (icon-7)

Bevacizumab is approved as a maintenance treatment in first-line setting in advanced-stage III-IV ovarian cancers, because GOG-0218 and ICON-7 phase III trials demonstrated progression-free survival benefits. However, only the subgroup of patients with high-risk diseases (stage IV, and incompletely resected stage III) derived an overall survival (OS) gain in the ICON-7 trial (4.8 months). The modeled CA-125 elimination rate constant K (KELIM) parameter, based on the longitudinal CA- 125 kinetics during the first 100 days of chemotherapy, is a potential indicator of the tumor primary chemo-sensitivity. In the ICON-7 trial dataset, the OS of patients within the low- and high-risk disease groups was assessed according to treatment arms and KELIM. Among the patients with high-risk diseases, those with favorable standardized KELIM of at least 1.0 (n=214, 46.7%) had no survival benefit from bevacizumab, whereas those with unfavorable KELIM less than 1.0 (n=244, 53.2%) derived the highest OS benefit (absolute difference = 9.1 months, 2-sided log-rank P=.10; Cox hazard ratio = 0.78, 95% confidence interval = 0.58 to 1.04, 2-sided P=.09)

Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)

Bevacizumab is approved as a maintenance treatment in first-line setting in advanced-stage III-IV ovarian cancers, because GOG-0218 and ICON-7 phase III trials demonstrated progression-free survival benefits. However, only the subgroup of patients with high-risk diseases (stage IV, and incompletely resected stage III) derived an overall survival (OS) gain in the ICON-7 trial (4.8 months). The modeled CA-125 elimination rate constant K (KELIM) parameter, based on the longitudinal CA-125 kinetics during the first 100 days of chemotherapy, is a potential indicator of the tumor primary chemo-sensitivity. In the ICON-7 trial dataset, the OS of patients within the low- and high-risk disease groups was assessed according to treatment arms and KELIM. Among the patients with high-risk diseases, those with favorable standardized KELIM of at least 1.0 (n = 214, 46.7%) had no survival benefit from bevacizumab, whereas those with unfavorable KELIM less than 1.0 (n = 244, 53.2%) derived the highest OS benefit (absolute difference = 9.1 months, 2-sided log-rank P = .10; Cox hazard ratio = 0.78, 95% confidence interval = 0.58 to 1.04, 2-sided P = .09)

Benthic foraminifera as tracers of brine production in the Storfjorden "sea ice factory"

The rapid response of benthic foraminifera to environmental factors (e.g. organic matter quality and quantity, salinity, pH) and their high fossilisation potential make them promising bio-indicators for the intensity and recurrence of brine formation in Arctic seas. Such an approach, however, requires a thorough knowledge of their modern ecology in such extreme settings. To this aim, seven stations along a north-south transect across the Storfjorden (Svalbard archipelago) have been sampled using an interface multicorer. This fjord is an area of intense sea ice formation characterised by the production of brine-enriched shelf waters (BSW) as a result of a recurrent latent-heat polynya. Living (rose bengal-stained) foraminiferal assemblages were analysed together with geochemical and sedimentological parameters in the top 5 cm of the sediment. Three major biozones were distinguished. (i) The inner fjord zone, dominated by typical glacier proximal calcareous species, which opportunistically respond to fresh organic matter inputs. (ii) The deep basins and sill zone, characterised by glacier distal agglutinated fauna; these are either dominant because of the mostly refractory nature of organic matter and/or the brine persistence that hampers the growth of calcareous species and/or causes their dissolution. (iii) The outer fjord zone, characterised by typical North Atlantic species due to the intrusion of the North Atlantic water in the Storfjordrenna. The stressful conditions present in the deep basins and sill (i.e. acidic waters and low food quality) result in a high agglutinated = calcareous ratio (A=C). This supports the potential use of the A=C ratio as a proxy for brine persistence and overflow in Storfjorden

Tcf7l2 plays pleiotropic roles in the control of glucose homeostasis, pancreas morphology, vascularization and regeneration

Type 2 diabetes (T2D) is a disease characterized by impaired insulin secretion. The Wnt signaling transcription factor Tcf7l2 is to date the T2D-associated gene with the largest effect on disease susceptibility. However, the mechanisms by which TCF7L2 variants affect insulin release from β-cells are not yet fully understood. By taking advantage of a tcf7l2 zebrafish mutant line, we first show that these animals are characterized by hyperglycemia and impaired islet development. Moreover, we demonstrate that the zebrafish tcf7l2 gene is highly expressed in the exocrine pancreas, suggesting potential bystander effects on β-cell growth, differentiation and regeneration. Finally, we describe a peculiar vascular phenotype in tcf7l2 mutant larvae, characterized by significant reduction in the average number and diameter of pancreatic islet capillaries. Overall, the zebrafish Tcf7l2 mutant, characterized by hyperglycemia, pancreatic and vascular defects, and reduced regeneration proves to be a suitable model to study the mechanism of action and the pleiotropic effects of Tcf7l2, the most relevant T2D GWAS hit in human populations. © 2017 The Author(s)

Ferramentas moleculares para garantir a qualidade de alimentos produzidos à base de mamão.

bitstream/item/164102/1/CT130-ferramentas-moleculares-mamao.pd

The energy landscape predicts flight height and wind turbine collision hazard in three species of large soaring raptor

Flight height was examined in a range of soaring raptors in order to predict the potential collision risk between these birds and wind turbines. This study developed a new method to account for the uncertainty in measurement of flight height from GPS-based measurements of altitude. The results indicate that species vary in their collision risk in line with expectations based on body size. In addition, collision risk can be predicted from thermal uplift potential. The new methods can be applied to other systems to examine collision risk

Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205+ dendritic cells

Two major distinct subsets of dendritic cells (DCs) are arranged to regulate our immune responses in vivo; 33D1+ and DEC-205+ DCs. Using anti-33D1-specific monoclonal antibody, 33D1+ DCs were successfully depleted from C57BL/6 mice. When 33D1+ DC-depleted mice were stimulated with LPS, serum IL-12, but not IL-10 secretion that may be mediated by the remaining DEC-205+ DCs was markedly enhanced, which may induce Th1 dominancy upon TLR signaling. The 33D1+ DC-depleted mice, implanted with syngeneic Hepa1-6 hepatoma or B16-F10 melanoma cells into the dermis, showed apparent inhibition of already established tumor growth in vivo when they were subcutaneously (sc) injected once or twice with LPS after tumor implantation. Moreover, the development of lung metastasis of B16-F10 melanoma cells injected intravenously was also suppressed when 33D1+ DC-deleted mice were stimulated twice with LPS in a similar manner, in which the actual cell number of NK1.1+CD3− NK cells in lung tissues was markedly increased. Furthermore, intraperitoneal (ip) administration of a very small amount of melphalan (l-phenylalanine mustard; l-PAM) (0.25 mg/kg) in LPS-stimulated 33D1+ DC-deleted mice helped to induce H-2Kb-restricted epitope-specific CD8+ cytotoxic T lymphocytes (CTLs) among tumor-infiltrating lymphocytes against already established syngeneic E.G7-OVA lymphoma. These findings indicate the importance and effectiveness of selective targeting of a specific subset of DCs, such as DEC-205+ DCs alone or with a very small amount of anticancer drugs to activate both CD8+ CTLs and NK effectors without externally added tumor antigen stimulation in vivo and provide a new direction for tumor immunotherapy

The DNA Glycosylases Ogg1 and Nth1 Do Not Contribute to Ig Class Switching in Activated Mouse Splenic B Cells

During activation of B cells to undergo class switching, B cell metabolism is increased, and levels of reactive oxygen species (ROS) are increased. ROS can oxidize DNA bases resulting in substrates for the DNA glycosylases Ogg1 and Nth1. Ogg1 and Nth1 excise oxidized bases, and nick the resulting abasic sites, forming single-strand DNA breaks (SSBs) as intermediates during the repair process. In this study, we asked whether splenic B cells from mice deficient in these two enzymes would show altered class switching and decreased DNA breaks in comparison with wild-type mice. As the c-myc gene frequently recombines with the IgH S region in B cells induced to undergo class switching, we also analyzed the effect of deletion of these two glycosylases on DSBs in the c-myc gene. We did not detect a reduction in S region or c-myc DSBs or in class switching in splenic B cells from Ogg1- or Nth1-deficient mice or from mice deficient in both enzymes